The U.S. Point of Care (PoC) Diagnostics Market is experiencing strong growth as healthcare providers increasingly prioritize rapid testing, decentralized diagnostics, and real-time clinical decision-making. Point-of-care diagnostics enable healthcare professionals to conduct medical testing near the patient instead of relying on centralized laboratory systems. These technologies are transforming healthcare delivery by improving accessibility, reducing turnaround times, and supporting faster treatment decisions.

According to industry analysis, the U.S. Point of Care (PoC) Diagnostics Market was valued at USD 9.69 billion in 2024 and is projected to reach USD 18.83 billion by 2034, registering a CAGR of 6.88% during the forecast period from 2025 to 2034. The increasing prevalence of chronic diseases, technological advancements in portable diagnostics, and rising demand for rapid testing solutions are key factors driving market expansion.

One of the major growth drivers for the U.S. Point of Care (PoC) Diagnostics Market is the growing demand for decentralized healthcare services. Hospitals, clinics, pharmacies, and home healthcare providers are increasingly adopting PoC diagnostic devices to improve patient convenience and reduce dependence on centralized laboratories. These systems allow healthcare professionals to diagnose and monitor diseases quickly, improving patient outcomes and operational efficiency.

Technological advancements are significantly transforming the market landscape. Modern point-of-care diagnostic systems now integrate digital connectivity, portable medical devices, and advanced molecular testing platforms. These innovations support seamless integration with electronic health records (EHRs), enabling healthcare providers to access real-time diagnostic information and improve patient monitoring capabilities. AI-enabled analytics and connected healthcare systems are further enhancing the efficiency of PoC diagnostics in the United States.

Read More @ https://www.polarismarketresearch.com/industry-analysis/us-point-of-care-diagnostics-market

The infectious diseases segment accounted for 36.91% of total market revenue in 2024 due to rising demand for rapid and accurate disease detection solutions. Point-of-care diagnostics are increasingly used for detecting respiratory infections, sexually transmitted diseases, influenza, RSV, and other infectious conditions. The ability to deliver immediate results makes PoC testing particularly valuable in emergency care and outpatient settings.

The clinics segment held 36.82% market share in 2024 as clinics continue to serve as major centers for rapid diagnostic testing across the United States. Increasing patient visits, expansion of urgent care centers, and growing emphasis on preventive healthcare are contributing to the adoption of PoC diagnostics in clinical settings.

North America continues to lead the broader point-of-care diagnostics industry due to advanced healthcare infrastructure, strong technology adoption, and increasing investments in digital healthcare transformation. As healthcare systems continue prioritizing rapid testing and patient-centered care, the U.S. Point of Care (PoC) Diagnostics Market is expected to maintain strong long-term growth.

More Trending Latest Reports By Polaris Market Research:

Property Management Software Market

Video Analytics Market

Edge AI market

Pharmaceutical Contract Development & Manufacturing Organization Market

Europe Subcutaneous Immunoglobulin Market

Kyphoplasty Market

Obesity Treatment Market

Quillaia Extracts Market

Automation Testing Market